|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1701 to 1800 out of 2260 for Erbb2

0.019s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Gabai VL
Year: 2012
Journal: Mol Cell Biol
Title: Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR.
Volume: 32
Issue: 5
Pages: 929-40
Publication
First Author: Chen X
Year: 2016
Journal: PLoS One
Title: CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.
Volume: 11
Issue: 11
Pages: e0165595
Publication
First Author: Miranda-Carboni GA
Year: 2008
Journal: Genes Dev
Title: A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors.
Volume: 22
Issue: 22
Pages: 3121-34
Publication
First Author: Sangrar W
Year: 2015
Journal: Oncogene
Title: Amplified Ras-MAPK signal states correlate with accelerated EGFR internalization, cytostasis and delayed HER2 tumor onset in Fer-deficient model systems.
Volume: 34
Issue: 31
Pages: 4109-17
Publication
First Author: Bentires-Alj M
Year: 2007
Journal: Cancer Res
Title: Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.
Volume: 67
Issue: 6
Pages: 2420-4
Publication  
First Author: Oh S
Year: 2018
Journal: Cell Signal
Title: Egr-1 is required for neu/HER2-induced mammary tumors.
Volume: 45
Pages: 102-109
Publication
First Author: Petrova SC
Year: 2020
Journal: Oncotarget
Title: Regulation of breast cancer oncogenesis by the cell of origin's differentiation state.
Volume: 11
Issue: 43
Pages: 3832-3848
Publication  
First Author: Ahn R
Year: 2017
Journal: Nat Commun
Title: The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression.
Volume: 8
Pages: 14638
Publication
First Author: Yori JL
Year: 2014
Journal: Cancer Res
Title: Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression.
Volume: 74
Issue: 17
Pages: 4762-71
Publication  
First Author: Wu H
Year: 2023
Journal: Int J Mol Sci
Title: Dietary Supplementation of Inulin Contributes to the Prevention of Estrogen Receptor-Negative Mammary Cancer by Alteration of Gut Microbial Communities and Epigenetic Regulations.
Volume: 24
Issue: 10
Publication
First Author: Dong Y
Year: 2014
Journal: Cell Res
Title: Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis.
Volume: 24
Issue: 11
Pages: 1354-66
Publication
First Author: Sheng G
Year: 2021
Journal: PLoS One
Title: Reduction of fibrosis and immune suppressive cells in ErbB2-dependent tumorigenesis by an LXR agonist.
Volume: 16
Issue: 3
Pages: e0248996
Publication
First Author: Sizemore GM
Year: 2017
Journal: Oncogene
Title: Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1.
Volume: 36
Issue: 16
Pages: 2297-2308
Publication
First Author: Grosset AA
Year: 2016
Journal: PLoS One
Title: Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.
Volume: 11
Issue: 11
Pages: e0166731
Publication
First Author: Ursini-Siegel J
Year: 2010
Journal: Cancer Res
Title: Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.
Volume: 70
Issue: 20
Pages: 7776-87
Publication
First Author: Andreani C
Year: 2023
Journal: Sci Rep
Title: SIRT6 promotes metastasis and relapse in HER2-positive breast cancer.
Volume: 13
Issue: 1
Pages: 22000
Publication
First Author: Itah Z
Year: 2023
Journal: Proc Natl Acad Sci U S A
Title: HER2-driven breast cancer suppression by the JNK signaling pathway.
Volume: 120
Issue: 4
Pages: e2218373120
Publication
First Author: Rowson-Hodel AR
Year: 2018
Journal: Oncogene
Title: Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
Volume: 37
Issue: 2
Pages: 197-207
Publication
First Author: Hutchinson JN
Year: 2004
Journal: Cancer Res
Title: Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
Volume: 64
Issue: 9
Pages: 3171-8
Publication
First Author: MacLennan MB
Year: 2013
Journal: J Nutr Biochem
Title: Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids.
Volume: 24
Issue: 1
Pages: 388-95
Strain
Attribute String: coisogenic, mutant strain, transgenic
Strain
Attribute String: coisogenic, mutant strain, transgenic
Publication
First Author: Pedersen K
Year: 2009
Journal: Mol Cell Biol
Title: A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis.
Volume: 29
Issue: 12
Pages: 3319-31
Genotype
Symbol: Tg(MMTV-ERBB3)1Slg/? Tg(MMTVneu)202Mul/?
Background: involves: FVB
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Etv4/Etv4 Tg(MMTVneu)202Mul/Tg(MMTVneu)202Mul
Background: involves: FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Erbb2/Erbb2 Tg(Ckmm-cre)5Khn/?
Background: involves: 129S1/Sv * 129X1/SvJ * BALB/c * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Ccnd1/Ccnd1 Tg(MMTV-Erbb2)NK1Mul/?
Background: involves: 129S4/SvJae * C57BL/6 * FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Erbb2/Erbb2 Myl2/Myl2<+>
Background: involves: 129P2/OlaHsd * 129S4/SvJae
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Tg(CAG-Has2)99Nita/? Tg(MMTVneu)202Mul/?
Background: FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTVneu)202Mul
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Akt3/Akt3 Tg(MMTV-Erbb2)NK1Mul/Tg(MMTV-Erbb2)NK1Mul
Background: involves: 129 * C57BL/6 * FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Pik3cb/Pik3cb Tg(MMTVneu)202Mul/?
Background: involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J * FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Pten/Pten Tg(MMTVneu)202Mul/? Tg(S100a4-cre)1Gle/?
Background: involves: FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Ccnd1/Ccnd1 Tg(MMTV-Erbb2)NK1Mul/?
Background: involves: 129S4/SvJae * C57BL/6 * FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Erbb2/Erbb2<+> Pten/Pten<+> Tg(MMTV-cre)7Mul/?
Background: involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Erbb2/Erbb2<+> Pten/Pten Tg(MMTV-cre)7Mul/?
Background: involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Ccnd1/Ccnd1<+> Tg(MMTVneu)202Mul/? Tg(tetO-Ccnd1*T286A,-luc)11233Kuw/?
Background: involves: 129S2/SvPas * FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Ccnd1/Ccnd1<+> Tg(MMTVneu)202Mul/? Tg(tetO-Ccnd1*T286A,-luc)10897Kuw/?
Background: involves: 129S2/SvPas * FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Ccnd1/Ccnd1 Tg(MMTVneu)202Mul/? Tg(tetO-Ccnd1*T286A,-luc)11233Kuw/?
Background: involves: 129S2/SvPas * FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Ccnd1/Ccnd1 Tg(MMTVneu)202Mul/? Tg(tetO-Ccnd1*T286A,-luc)10897Kuw/?
Background: involves: 129S2/SvPas * FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Ccnd1/Ccnd1 Tg(MMTVneu)202Mul/?
Background: involves: 129S2/SvPas * FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Tg(MMTV-ERBB2*)#Arbs/?
Background: FVB-Tg(MMTV-ERBB2*)#Arbs
Zygosity: ot
Has Mutant Allele: true
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length: 479  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 481  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 189  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 189  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 189  
Fragment?: false
Publication
First Author: Sukhanova A
Year: 2013
Journal: Cancer Discov
Title: Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation.
Volume: 3
Issue: 1
Pages: 96-111
Publication
First Author: Tao Y
Year: 2016
Journal: Carcinogenesis
Title: Hsp70 exerts oncogenic activity in the Apc mutant Min mouse model.
Volume: 37
Issue: 7
Pages: 731-739
Publication
First Author: Lee D
Year: 2009
Journal: J Clin Invest
Title: Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium.
Volume: 119
Issue: 9
Pages: 2702-13
Publication
First Author: Ruan YC
Year: 2014
Journal: J Cell Sci
Title: CFTR interacts with ZO-1 to regulate tight junction assembly and epithelial differentiation through the ZONAB pathway.
Volume: 127
Issue: Pt 20
Pages: 4396-408
Publication
First Author: Yoshioka T
Year: 2013
Journal: J Clin Invest
Title: β4 Integrin signaling induces expansion of prostate tumor progenitors.
Volume: 123
Issue: 2
Pages: 682-99
Publication
First Author: Vandekerckhove L
Year: 2016
Journal: Am J Physiol Endocrinol Metab
Title: Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk.
Volume: 310
Issue: 7
Pages: E495-504
Publication
First Author: Porzia A
Year: 2010
Journal: J Immunol
Title: Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies.
Volume: 184
Issue: 8
Pages: 4170-7
Publication
First Author: Yang C
Year: 2004
Journal: Am J Pathol
Title: The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer.
Volume: 164
Issue: 3
Pages: 1031-8
Publication
First Author: Cicchini M
Year: 2014
Journal: Autophagy
Title: Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Volume: 10
Issue: 11
Pages: 2036-52
Publication
First Author: Ghidinelli M
Year: 2017
Journal: PLoS Biol
Title: Laminin 211 inhibits protein kinase A in Schwann cells to modulate neuregulin 1 type III-driven myelination.
Volume: 15
Issue: 6
Pages: e2001408
Publication
First Author: Sinha VC
Year: 2015
Journal: Mol Cancer Res
Title: A p53/ARF-dependent anticancer barrier activates senescence and blocks tumorigenesis without impacting apoptosis.
Volume: 13
Issue: 2
Pages: 231-8
Publication
First Author: Seshadri S
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade.
Volume: 107
Issue: 12
Pages: 5622-7
Publication
First Author: Liu FF
Year: 2005
Journal: Am J Physiol Heart Circ Physiol
Title: Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure.
Volume: 289
Issue: 2
Pages: H660-6
Publication
First Author: Schmucker J
Year: 2003
Journal: Glia
Title: erbB3 is dispensable for oligodendrocyte development in vitro and in vivo.
Volume: 44
Issue: 1
Pages: 67-75
Publication
First Author: Stankovic K
Year: 2004
Journal: J Neurosci
Title: Survival of adult spiral ganglion neurons requires erbB receptor signaling in the inner ear.
Volume: 24
Issue: 40
Pages: 8651-61
Publication
First Author: Usui M
Year: 2002
Journal: J Bone Miner Res
Title: Enhancing effect of Tob deficiency on bone formation is specific to bone morphogenetic protein-induced osteogenesis.
Volume: 17
Issue: 6
Pages: 1026-33
Publication
First Author: Dahlhoff M
Year: 2013
Journal: Biochim Biophys Acta
Title: Increased activation of the epidermal growth factor receptor in transgenic mice overexpressing epigen causes peripheral neuropathy.
Volume: 1832
Issue: 12
Pages: 2068-76
Publication
First Author: Cadieux C
Year: 2009
Journal: Cancer Res
Title: Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
Volume: 69
Issue: 18
Pages: 7188-97
Publication
First Author: Logan AM
Year: 2017
Journal: Glia
Title: Schwann cell-specific deletion of the endosomal PI 3-kinase Vps34 leads to delayed radial sorting of axons, arrested myelination, and abnormal ErbB2-ErbB3 tyrosine kinase signaling.
Volume: 65
Issue: 9
Pages: 1452-1470
Publication
First Author: Song X
Year: 2015
Journal: Cancer Res
Title: ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas.
Volume: 75
Issue: 6
Pages: 1035-45
Publication
First Author: Hoesl C
Year: 2018
Journal: Biochim Biophys Acta
Title: The receptor tyrosine kinase ERBB4 is expressed in skin keratinocytes and influences epidermal proliferation.
Volume: 1862
Issue: 4
Pages: 958-966
Publication
First Author: Cook RS
Year: 2011
Journal: Cancer Res
Title: ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis.
Volume: 71
Issue: 11
Pages: 3941-51
Publication
First Author: Huebner RJ
Year: 2014
Journal: Development
Title: Developmental stratification of the mammary epithelium occurs through symmetry-breaking vertical divisions of apically positioned luminal cells.
Volume: 141
Issue: 5
Pages: 1085-94
Publication
First Author: Liu J
Year: 2015
Journal: Biochem Biophys Res Commun
Title: Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice.
Volume: 463
Issue: 4
Pages: 1230-6
Publication
First Author: Kuns R
Year: 2005
Journal: Oncogene
Title: Protein 4.1B expression is induced in mammary epithelial cells during pregnancy and regulates their proliferation.
Volume: 24
Issue: 43
Pages: 6502-15
Publication
First Author: Limpert AS
Year: 2010
Journal: J Biol Chem
Title: Axonal neuregulin 1 type III activates NF-kappaB in Schwann cells during myelin formation.
Volume: 285
Issue: 22
Pages: 16614-22
Publication  
First Author: Le TL
Year: 2021
Journal: J Clin Invest
Title: Dysregulation of the NRG1/ERBB pathway causes a developmental disorder with gastrointestinal dysmotility in humans.
Volume: 131
Issue: 6
Publication
First Author: Young CD
Year: 2011
Journal: PLoS One
Title: Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo.
Volume: 6
Issue: 8
Pages: e23205
Publication  
First Author: Ueda O
Year: 2017
Journal: Sci Rep
Title: Entire CD3ε, δ, and γ humanized mouse to evaluate human CD3-mediated therapeutics.
Volume: 7
Pages: 45839
Publication
First Author: Lemmens K
Year: 2011
Journal: Am J Physiol Heart Circ Physiol
Title: Activation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy.
Volume: 300
Issue: 3
Pages: H931-42
Publication
First Author: Jo SA
Year: 1995
Journal: Nature
Title: Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression.
Volume: 373
Issue: 6510
Pages: 158-61
Publication
First Author: Bafico A
Year: 1998
Journal: Oncogene
Title: Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts.
Volume: 16
Issue: 21
Pages: 2819-25
Publication
First Author: Wagner M
Year: 2002
Journal: Gastroenterology
Title: Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells.
Volume: 122
Issue: 7
Pages: 1898-912
Publication
First Author: Yang C
Year: 2006
Journal: Cancer Res
Title: Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.
Volume: 66
Issue: 24
Pages: 11649-58
Publication
First Author: Wu Q
Year: 2007
Journal: Cancer Res
Title: Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model.
Volume: 67
Issue: 8
Pages: 3794-800
Publication
First Author: Barrick CJ
Year: 2008
Journal: Toxicol Appl Pharmacol
Title: Chronic pharmacologic inhibition of EGFR leads to cardiac dysfunction in C57BL/6J mice.
Volume: 228
Issue: 3
Pages: 315-25
Publication
First Author: Fehrenbacher N
Year: 2008
Journal: Cancer Res
Title: Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
Volume: 68
Issue: 16
Pages: 6623-33
Publication
First Author: Liu M
Year: 2009
Journal: Am J Pathol
Title: Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo.
Volume: 174
Issue: 5
Pages: 1910-20
Publication
First Author: Ingalla EQ
Year: 2010
Journal: J Biol Chem
Title: Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors.
Volume: 285
Issue: 37
Pages: 28691-7
Publication
First Author: Liu M
Year: 2010
Journal: Cancer Res
Title: The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion.
Volume: 70
Issue: 24
Pages: 10464-73
Publication
First Author: Liu Y
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Neuregulin 1-β regulates cell adhesion molecule L1 expression in the cortex and hippocampus of mice.
Volume: 441
Issue: 1
Pages: 7-12
Publication
First Author: Haricharan S
Year: 2014
Journal: Oncogene
Title: Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer.
Volume: 33
Issue: 50
Pages: 5729-39
Publication
First Author: Torii T
Year: 2014
Journal: Biochem Biophys Res Commun
Title: In vivo knockdown of ErbB3 in mice inhibits Schwann cell precursor migration.
Volume: 452
Issue: 3
Pages: 782-8
Publication
First Author: Memmi EM
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: p63 Sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling.
Volume: 112
Issue: 11
Pages: 3499-504
Publication
First Author: Boulay PL
Year: 2016
Journal: Cancer Res
Title: Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.
Volume: 76
Issue: 9
Pages: 2662-74
Publication
First Author: Yang L
Year: 2016
Journal: Am J Hum Genet
Title: Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing.
Volume: 98
Issue: 5
Pages: 843-856
Publication
First Author: Horiuchi D
Year: 2016
Journal: Nat Med
Title: PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression.
Volume: 22
Issue: 11
Pages: 1321-1329
Publication
First Author: Alizadeh A
Year: 2017
Journal: Glia
Title: Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury.
Volume: 65
Issue: 7
Pages: 1152-1175
Publication
First Author: Simonis A
Year: 2014
Journal: PLoS Pathog
Title: Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of Neisseria meningitidis into brain endothelial cells.
Volume: 10
Issue: 6
Pages: e1004160
Publication
First Author: Gupta MK
Year: 2021
Journal: Sci Rep
Title: Cardiac expression of microRNA-7 is associated with adverse cardiac remodeling.
Volume: 11
Issue: 1
Pages: 22018